The market for medicines that treat pain is expected to expand at a rate of nearly 5% over the next six years with increasing numbers of people experiencing cancer, lower back pain, postsurgical pain and arthritis. This meeting will examine the products in development to treat chronic pain and how clinical trials for these indications should be designed and conducted.
Delegates will discuss case studies of drugs in preclinical and clinical development and the regulatory requirements for these therapies.